TY - JOUR
T1 - Treatment of experimental invasive aspergillosis with novel amphotericin b/cholesterol-sulfate complexes
AU - Patterson, Thomas F.
AU - Miniter, Peggy
AU - Dijkstra, Jan
AU - Szoka, Francis C.
AU - Ryan, John L.
AU - Andriole, Vincent T.
PY - 1989/4
Y1 - 1989/4
N2 - An immunosuppressed rabbit model of invasive aspergillosiswasused to evaluate a novel micellar preparation of cholesterol sulfate complexedto amphotericin B. The acute LDso of amphotericin B-deoxycholate was 5.1 mg/kg versus 20 mg/kg for the amphotericin/cholesterol-sulfate complexes. Amphotericin B-deoxycholate giveniv at a dose of 1.5 mg/kg wasmore effective in sterilizing liverand kidneythan the amphotericin/cholesterolsulfate complexes given iv at 1.5-4.5 mg/kg, but infection persisted in the lungs of all rabbits treated with those doses. Infection persisted even when the rabbits weregiven a lethal dose of amphotericin B-deoxycholate (4.5 mg/kg), but a dose of 15 mg/kg of the amphotericin/cholesterol-sulfate complexessterilized tissues and was associated with no acute lethality. Equivalent doses of the amphotericin/cholesterol-sulfate complexeswere lesseffectivethan amphotericin B-deoxycholate, but a fourfold decreasein acute lethality improvedthe therapeutic index of amphotericin B. The amphotericin/cholesterol-sulfate complexesappear to be an improvedmeans of amphotericin Bdeliveryand may improve therapy for invasive aspergillosis.
AB - An immunosuppressed rabbit model of invasive aspergillosiswasused to evaluate a novel micellar preparation of cholesterol sulfate complexedto amphotericin B. The acute LDso of amphotericin B-deoxycholate was 5.1 mg/kg versus 20 mg/kg for the amphotericin/cholesterol-sulfate complexes. Amphotericin B-deoxycholate giveniv at a dose of 1.5 mg/kg wasmore effective in sterilizing liverand kidneythan the amphotericin/cholesterolsulfate complexes given iv at 1.5-4.5 mg/kg, but infection persisted in the lungs of all rabbits treated with those doses. Infection persisted even when the rabbits weregiven a lethal dose of amphotericin B-deoxycholate (4.5 mg/kg), but a dose of 15 mg/kg of the amphotericin/cholesterol-sulfate complexessterilized tissues and was associated with no acute lethality. Equivalent doses of the amphotericin/cholesterol-sulfate complexeswere lesseffectivethan amphotericin B-deoxycholate, but a fourfold decreasein acute lethality improvedthe therapeutic index of amphotericin B. The amphotericin/cholesterol-sulfate complexesappear to be an improvedmeans of amphotericin Bdeliveryand may improve therapy for invasive aspergillosis.
UR - http://www.scopus.com/inward/record.url?scp=0024559833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024559833&partnerID=8YFLogxK
U2 - 10.1093/infdis/159.4.717
DO - 10.1093/infdis/159.4.717
M3 - Article
C2 - 2926162
AN - SCOPUS:0024559833
VL - 159
SP - 717
EP - 724
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
SN - 0022-1899
IS - 4
ER -